Myriad Genetics to Sell Prenatal Testing Business to Labcorp for $210M

Myriad Genetics agreed to sell its prenatal health business to Labcorp for $210 million in cash plus the value of inventory at closing. The asset sale includes Foresight Carrier Screen, Prequel Prenatal Screen, FirstGene 4-in-1 Prenatal Screen, and SneakPeek Early Gender Test, with Labcorp offering…